TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Pharmacorp Rx Inc. ( (TSE:PCRX) ).
PharmaCorp Rx Inc. announced the approval from the TSX Venture Exchange for the supplemental listing of 27,427,500 common share purchase warrants, which will be available for trading starting November 17, 2025. This move is part of the company’s strategy to enhance its financial operations and expand its market presence, potentially impacting its growth and acquisition capabilities in the pharmacy sector.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform that focuses on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. The company is building a national network of community pharmacies under the PharmaChoice Canada banner and currently operates seven such pharmacies. PharmaCorp aims to acquire both PharmaChoice Canada bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform.
Average Trading Volume: 77,617
Technical Sentiment Signal: Sell
Current Market Cap: C$49.48M
Find detailed analytics on PCRX stock on TipRanks’ Stock Analysis page.